Table 2.
Multiple Logistic Regression Model Adjusted Odds of Protocol Action and Treatment Delivery, by Implementation Period
| Variablea | Preimplementation Period (n = 1,761)b | Postimplementation Period (n = 2,214) | |||||
|---|---|---|---|---|---|---|---|
| Received NRT | Referred to WTQL | Any Treatment | Pharmacist Addressed Tobacco Use | Received NRT | Referred to WTQL | Any Treatment | |
| Age | 0.99 (0.99, 1.00) | 1.04 (0.99, 1.09) | 0.99 (0.99, 1.00) | 1.01 (1.00, 1.02)c | 0.99 (0.99, 1.00)c | 1.01 (1.00, 1.02) | 0.99 (0.99, 1.00)c |
| Sex (male reference group) | |||||||
| Female | 0.75 (0.62, 0.92)c | 0.55 (0.19, 1.63) | 0.76 (0.63, 0.93)c | 0.89 (0.75, 1.06) | 0.93 (0.79, 1.11) | 0.96 (0.74, 1.25) | 0.96 (0.81, 1.14) |
| Race (White reference group) | |||||||
| Black | 0.62 (0.45, 0.87)c | NAd | 0.62 (0.44, 0.86)c | 0.84 (0.64, 1.11) | 0.72 (0.54, 0.95)c | 1.10 (0.73, 1.66) | 0.73 (0.55, 0.97)c |
| Other/unknown | 0.81 (0.45, 1.46) | NAd | 0.80 (0.45, 1.44) | 0.78 (0.47, 1.31) | 0.77 (0.46, 1.29) | 0.50 (0.19, 1.35) | 0.70 (0.42, 1.17) |
| Ethnicity (Non-Hispanic reference group) | |||||||
| Hispanic | 0.38 (0.19, 0.75)c | 3.90 (0.46, 33.05) | 0.38 (0.19, 0.75)c | 1.14 (0.70, 1.84) | 0.64 (0.40, 1.03) | 0.83 (0.37, 1.86) | 0.66 (0.41, 1.06) |
| Other/unknown | 1.60 (0.68, 3.74) | NAd | 1.59 (0.68, 3.73) | 2.14 (0.89, 5.18) | 1.67 (0.74, 3.76) | 1.22 (0.30, 4.96) | 1.64 (0.73, 3.71) |
| Insurance (commercial reference group) | |||||||
| Medicaid | 1.53 (1.21, 1.95)c | 0.98(0.24, 3.98) | 1.56 (1.22, 1.98)c | 1.05(0.85, 1.31) | 1.50 (1.21, 1.86)c | 0.90(0.65, 1.25) | 1.45 (1.17, 1.79)c |
| Medicare | 1.08(0.84, 1.39) | 0.67(0.20, 2.27) | 1.07(0.83, 1.38) | 0.99(0.78, 1.25) | 1.24(0.99, 1.56) | 0.82(0.58, 1.15) | 1.21(0.96, 1.51) |
| Other/unknown | 0.84(0.37, 1.9) | NAd | 0.83(0.37, 1.88) | 0.47(0.21, 1.05) | 1.49(0.66, 3.37) | 0.24(0.03, 1.80) | 1.33(0.59, 3.00) |
| Primary diagnosis (diagnoses other than those listed below reference group) | |||||||
| Cancer | 0.61(0.3, 1.22) | NAd | 0.60(0.30, 1.21) | 1.33(0.77, 2.31) | 1.21(0.73, 1.99) | 1.69(0.88, 3.24) | 1.19(0.72, 1.96) |
| CVMD | 1.06(0.8, 1.39) | 1.74(0.52, 5.77) | 1.06(0.81, 1.40) | 0.91(0.71, 1.17) | 1.32 (1.03, 1.68)c | 1.54 (1.10, 2.16)c | 1.46 (1.14, 1.86)c |
| Pulmonary | 1.8(0.96, 3.41) | 5.69 (1.12, 29.02)c | 1.78(0.94, 3.35) | 1.34(0.76, 2.37) | 1.55(0.92, 2.61) | 0.95(0.42, 2.14) | 1.52(0.90, 2.57) |
Abbreviations: CVMD, cardiovascular or metabolic disease; NA, not available; NRT, nicotine replacement therapy; WTQL, Wisconsin Tobacco Quit Line.
aData are shown as odds ratio (95% confidence interval).
bExcludes 4 pilot services.
cStatistically significant difference (P < 0.05).
dModel estimates did not converge due to low numbers of observations.